{"nct_id":"NCT01718353","title":"Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2013-03","start_date_type":null,"primary_completion_date":"2015-08","primary_completion_date_type":"ACTUAL","completion_date":"2015-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}